Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review.

ABSTRACT:

Background

Continuing progress in the global pediatric human immunodeficiency virus (HIV) response depends on timely identification and care of infants with HIV. As countries scale-out improvements to HIV early infant diagnosis (EID), economic evaluations are needed to inform program design and implementation. This scoping review aimed to summarize the available evidence and discuss practical implications of cost and cost-effectiveness analyses of HIV EID.

Methods

We systematically searched bibliographic databases (Embase, MEDLINE and EconLit) and grey literature for economic analyses of HIV EID in low- and middle-income countries published between January 2008 and June 2021. We extracted data on unit costs, cost savings, and incremental cost-effectiveness ratios as well as

SUBMITTER: Elsbernd K 

PROVIDER: S-EPMC9284833 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature